Apr 24 |
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
|
Apr 24 |
Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
Apr 24 |
3 No-Brainer Stocks to Buy With $300 Right Now
|
Apr 22 |
A Closer Look At Jazz Pharmaceuticals plc's (NASDAQ:JAZZ) Uninspiring ROE
|
Apr 18 |
Jazz Pharmaceuticals: Cheap But Complicated
|
Apr 17 |
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
|
Apr 15 |
Jazz Pharmaceuticals: Targeting The Low-Hanging Fruit In Oncology Might Pay Off
|
Apr 10 |
Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
|